A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient

被引:12
|
作者
Liu, Yihui [1 ]
Xu, Jiang [2 ]
Tao, Wanyun [3 ]
Yu, Rong [4 ]
Zhang, Xinjiang [1 ,2 ]
机构
[1] Yangzhou Univ, Dept Neurol, Affiliated Hosp, Yangzhou 225000, Jiangsu, Peoples R China
[2] Yangzhou Univ, Med Sch, Yangzhou, Jiangsu, Peoples R China
[3] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
[4] Cent S Univ, XiangYa Hosp 2, Dept Anesthesiol, Changsha, Hunan, Peoples R China
关键词
Hypertriglyceridemia; HTG; LMF1; Compound mutation; LIPOPROTEIN-LIPASE; ENDOPLASMIC-RETICULUM; TRIGLYCERIDE; DEFICIENCY; ENZYME; LETHAL; GENE;
D O I
10.5551/jat.44537
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Aim: Dyslipidemia is the most common lipid metabolism disorder in humans, and its etiology remains elusive. Hypertriglyceridemia (HTG) is a type of dyslipidemia that contributes to atherosclerosis and coronary heart disease. Previous studies have demonstrated that mutations in lipoprotein lipase (LPL), apolipoprotein CII (APOC2), apolipoprotein AV (APOA5), glycosylphosphatidylinositol anchored high-density lipoprotein-binding protein 1 (GPIHBP1), lipase maturation factor 1 (LMF1), and glycerol-3 phosphate dehydrogenase 1 (GPD1) are responsible for HTG by using genomic microarrays and next-generation sequencing. The aim of this study was to identify genetic lesions in patients with HTG. Method: Our study included a family of seven members from Jiangsu province across three generations. The proband was diagnosed with severe HTG, with a plasma triglyceride level of 38.70 mmol/L. Polymerase chain reaction (PCR) and Sanger sequencing were performed to explore the possible causative gene mutations for this patient. Furthermore, we measured the post-heparin LPL and hepatic lipase (HL) activities using an antiserum inhibition method. Results: A compound heterozygous mutation in the LMF1 gene (c.257C>T/p.P86L and c.1184C>T/p. T3951) was identified and co-segregated with the affected patient in this family. Both mutations were predicted to be deleterious by three bioinformatics programs (Polymorphism Phenotyping-2, Sorting Intolerant From Tolerant, and MutationTaster). The levels of the plasma post-heparin LPL and HL activities in the proband (57 and 177 mU/mL) were reduced to 24% and 75%, respectively, compared with those assayed in the control subject with normal plasma triglycerides. Conclusion: A compound heterozygous mutation of LMF1 was identified in the presenting patient with severe HTG. These findings expand on the spectrum of LMF1 mutations and contribute to the genetic diagnosis and counseling of families with HTG.
引用
收藏
页码:136 / 144
页数:9
相关论文
共 50 条
  • [21] A compound heterozygous mutation of CYP27A1 gene in a Taiwanese patient with cerebrotendinous xanthomatosis
    Chen, Wen-Chau
    Wu, Kuo-Chen
    Hu, Chih-Hsiung
    Chern, Tai-Chang
    Jou, I-Ming
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2011, 16 (06) : 825 - 827
  • [22] Novel compound heterozygous mutation of MLYCD in a Chinese patient with malonic aciduria
    Xue, Jinjie
    Peng, Jing
    Zhou, Mingxing
    Zhong, Le
    Yin, Fei
    Liang, Desheng
    Wu, Lingqian
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (01) : 79 - 83
  • [23] Identification of a compound heterozygous mutation of ABCC2 in a patient with hyperbilirubinemia
    Xiang, Rong
    Li, Jing-Jing
    Fan, Liang-Liang
    Jin, Jie-Yuan
    Xia, Kun
    Wang, Fang
    MOLECULAR MEDICINE REPORTS, 2017, 16 (03) : 2830 - 2834
  • [24] Compound Heterozygous Polymerase Gamma Gene Mutation in a Patient With Alpers Disease
    Cardenas, Javier F.
    Amato, R. Stephen
    SEMINARS IN PEDIATRIC NEUROLOGY, 2010, 17 (01) : 62 - 64
  • [25] Lipase maturation factor 1: structure and role in lipase folding and assembly
    Doolittle, Mark H.
    Ehrhardt, Nicole
    Peterfy, Miklos
    CURRENT OPINION IN LIPIDOLOGY, 2010, 21 (03) : 198 - 203
  • [26] Lipase maturation factor 1: A lipase chaperone involved in lipid metabolism
    Peterfy, Miklos
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2012, 1821 (05): : 790 - 794
  • [27] A compound heterozygous Thrombasthenia Glanzmann patient with a missense mutation and a frameshift mutation in the GPIIIA-subunit
    Westrup, D.
    Pilgrimm, A.
    Klamroth, R.
    Scholz, T.
    Pillitteri, D.
    Krause, M.
    Kirchmaier, C. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 575 - 575
  • [28] A novel compound heterozygous mutation in the COA7 gene responsible for a Chinese patient with spinocerebellar ataxia with axonal neuropathy type 3
    Tang, Yuwei
    Yu, Meng
    Zhang, Wei
    Lv, He
    Deng, Jianwen
    Liu, Jing
    Shi, Xin
    Liang, Wei
    Jia, Zhirong
    Yuan, Yun
    Wang, Zhaoxia
    Meng, Lingchao
    CLINICAL NEUROPATHOLOGY, 2022, 41 (05) : 202 - 210
  • [29] Phialophora americana infection in a patient with a compound heterozygous CARD9 mutation
    Jie Wu
    Yang Xiang
    Fengming Li
    Xiaodong Liu
    Ningning Dang
    Jing Guo
    BMC Infectious Diseases, 25 (1)
  • [30] A novel compound heterozygous mutation in TTC8 identified in a Japanese patient
    Shigeru Sato
    Takeshi Morimoto
    Kikuko Hotta
    Takashi Fujikado
    Kohji Nishida
    Human Genome Variation, 6